


| Key | % Net Assets |
|---|---|
| 7.9% | |
| 6.6% | |
| 5.7% | |
| 4.6% | |
| 75.2% |
| Name | % Net Assets |
|---|---|
| GlaxoSmithKline PLC | 7.9% |
| Vodafone Group PLC | 6.6% |
| Astrazeneca | 5.7% |
| British American Tobacco PLC | 4.6% |
| Unilever PLC | 4.3% |
| Cable & Wireless PLC | 4.1% |
| Cadbury PLC | 3.5% |
| Morrison (WM) Supermarkets PLC | 3.2% |
| Synergy Health PLC | 3.2% |
| Compass Group PLC | 3.1% |
No asset data available.
| Date | n/a |
|---|---|
| Bid | 0.00 |
| Offer | 0.00 |
| Currency | n/a |
| Change | 0.00 |
| % | n/a |
| YTD change | 0.00 |
| YTD % | n/a |
| Fund Inception | 01/12/1992 |
|---|---|
| Fund Manager | Richard Wilmot |
| TER | 1.63 (30-Dec-2011) |
| Minimum Investment | |
|---|---|
| Initial | 1000 |
| Additional | 250 |
| Savings | 50 |
| Charges | |
|---|---|
| Initial | 4.00% |
| Annual Mang't | 1.50% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.19 |
You are here: research